GSA Capital Partners’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-53,030
| Closed | -$53K | – | 1802 |
|
|
2025
Q1 | $53K | Buy |
+53,030
| New | +$53K | ﹤0.01% | 1544 |
|
|
2022
Q2 | – | Sell |
-131,655
| Closed | -$420K | – | 1457 |
|
|
2022
Q1 | $420K | Buy |
131,655
+118,652
| +912% | +$379K | 0.06% | 655 |
|
|
2021
Q4 | $54K | Buy |
+13,003
| New | +$54K | 0.01% | 1348 |
|
|
2020
Q2 | – | Sell |
-75,869
| Closed | -$586K | – | 700 |
|
|
2020
Q1 | $586K | Buy |
75,869
+10,899
| +17% | +$84.2K | 0.15% | 104 |
|
|
2019
Q4 | $250K | Buy |
64,970
+32,150
| +98% | +$124K | 0.03% | 1148 |
|
|
2019
Q3 | $165K | Buy |
+32,820
| New | +$165K | 0.02% | 1210 |
|
|
2019
Q2 | – | Sell |
-16,882
| Closed | -$128K | – | 1487 |
|
|
2019
Q1 | $128K | Buy |
+16,882
| New | +$128K | 0.01% | 1309 |
|